DNP860 Module 3 Evidence Appraisal Paper Example

Reviewed by Maren Hollowell, MSN, RN Aspen University Updated October 2026

This DNP860 Module 3 sample paper grades five sources on reducing blood culture contamination on the Johns Hopkins level and quality scales, instead of only summarizing what they found. In Aspen University's Evidence-Based Practice for Quality Improvement, the third module of the DNP course asks students how much confidence each study deserves. The sources are Snyder's systematic review of collection practices, Rupp's within-patient trial of a diversion device with 904 patients, Self's sterile collection project in which contamination fell from 4.3 to 1.7 percent, Doern's review and Skoglund's economic model. Each receives a level and a quality grade with reasons. A synthesis shows the evidence is strongest for venipuncture and trained collectors and weakest for kits alone, and the gaps section points out that the three bundle parts were never tested as a set.

CourseDNP860 Evidence-Based Practice for Quality Improvement
ModuleModule 3
Paper typeEvidence appraisal paper
LengthAbout 1,084 words, 6 pages
FormatAPA 7 student paper
SchoolAspen University
ProgramDNP
UpdatedOctober 2026

Free sample paper for DNP860 Module 3

1

Level and Quality, Not Just Findings: Appraising the Evidence for a Blood Culture Collection Bundle Using the Johns Hopkins Model

Student Name

Doctor of Nursing Practice Program, Aspen University

DNP860: Evidence-Based Practice for Quality Improvement

Instructor Name

Month Day, Year

What this page is doingThe title states the discipline of appraisal the module asks for, judging strength and quality rather than summarizing, and names the model used. APA 7 student title page for a doctoral program.
2

Level and Quality, Not Just Findings: Appraising the Evidence for a Blood Culture Collection Bundle Using the Johns Hopkins Model

Summarizing what studies found is not appraisal. Appraisal asks how much confidence each finding deserves, based on the study's design and how well it was conducted. This paper appraises five key sources from the search on reducing blood culture contamination using the Johns Hopkins evidence-based practice model's levels of evidence and quality ratings, then considers what the body of evidence supports for each component of the proposed collection bundle.

What this page is doingThe introduction distinguishes appraisal from summary and names the model, which sets the standard for the paper.
3

The Appraisal Framework

The Johns Hopkins model rates research evidence on five levels (Dang et al., 2021). The top level holds experimental work, such as randomized trials, along with systematic reviews built from such trials. The second level covers quasi-experimental studies and systematic reviews of quasi-experimental studies, alone or combined with trials. Level III includes nonexperimental and qualitative studies and systematic reviews that include them. Level IV includes the opinions of respected authorities and nationally recognized expert committees, such as clinical practice guidelines and consensus panels. Level V includes literature reviews, quality improvement projects, program evaluations, financial evaluations, case reports, and expert opinion. Each source also receives a quality grade, with A for high quality, B for good quality with some limitations, and C for low quality or major flaws, judged on sample size, control, consistency, and the clarity of methods and conclusions.

What this page is doingThe framework's levels and quality ratings are described accurately from the source, providing the criteria used throughout.
4

Source 1: Systematic Review and Meta-Analysis of Collection Practices

Snyder et al. (2012) conducted a systematic review and meta-analysis for a laboratory medicine best practices initiative, including 9 studies of venipuncture compared with catheter draws, 5 of phlebotomy teams, and 7 of preparation kits. All studies favored venipuncture and phlebotomy teams, with mean odds ratios of 2.69 and 2.58 for contamination with the comparison practices, while preparation kits showed no clear effect. Level: III, because most included studies were observational. Quality: A, because the review used a transparent, systematic method with explicit rating of study quality and consistent findings. What it supports: separate venipuncture and dedicated, trained collectors. What it does not support: the use of prepackaged kits alone.

What this page is doingEach source is described, rated on level and quality with reasons, and stated in terms of what it supports and does not, which is the core of appraisal.
5

Source 2: A Within-Patient Trial of Diverting the First Milliliters

Rupp et al. (2017) conducted a prospective controlled trial in an academic emergency department in which 904 patients each had one culture set collected with a device that diverts the first 1.5 to 2 milliliters of blood and one collected by standard procedure. Contamination was 0.22 percent with the device and 1.78 percent with standard collection, and the detection of true bacteremia was not reduced. Level: II, a controlled but not randomized comparison. Quality: B, strong within-patient design and large sample, but conducted at a single academic site with staff who knew they were being studied, which calls for caution about how well the effect will carry over to routine practice elsewhere. What it supports: adding diversion to the bundle.

What this page is doingThe trial's design, results and limitations, including potential conflicts, are appraised honestly, which shows critical judgment rather than acceptance.
6

Source 3: Interrupted Time Series Quality Improvement Study

Self et al. (2013) reported a quality improvement study in an emergency department that converted blood culture collection from a clean to a fully sterile procedure. Contamination fell from 4.3 percent of 7,389 cultures at baseline to 1.7 percent of 6,590 during the intervention, with segmented regression showing an immediate absolute reduction of 2.9 percentage points, sustained below 3 percent throughout the intervention period. Level: V, as a quality improvement study under the Johns Hopkins hierarchy. Quality: A, because the interrupted time series design and segmented regression provide stronger inference than a simple before-and-after comparison, and the setting closely matches ours. Its level is the lowest, but its fit with our department is the closest, and appraisal must weigh both.

What this page is doingThe appraisal explains why a lower-level source can still be highly informative, and the highlighted sentence captures the balance between strength and applicability.
7

Source 4: Comprehensive Review

Doern et al. (2019) published a comprehensive review of blood culture contamination for clinical microbiology laboratories, covering its scope, common contaminants, consequences, and methods of prevention. Level: V, a literature review with expert guidance. Quality: A, written by recognized experts with extensive referencing. What it supports: the significance of the problem, the definition of contamination, and the plausibility of combining several practices; it is not direct evidence of effectiveness.

What this page is doingThe review is correctly placed as background and guidance rather than effectiveness evidence.
8

Source 5: Economic Decision Analysis

Skoglund et al. (2019) built a decision analysis model estimating the costs and benefits of routine use of a diversion device in an emergency department. The model found the device cost-beneficial, with savings driven mainly by the baseline contamination rate and the duration of antibiotics given to patients with falsely positive cultures. Level: V, a financial evaluation. Quality: B, because the model's results depend on assumptions drawn from the literature and one institution's data. What it supports: a business case for diversion, especially where baseline contamination is high, as it is in our department.

What this page is doingThe economic model is appraised with attention to its dependence on assumptions and linked to local relevance.
9

What the Body of Evidence Supports

Taken together, the evidence is strongest for separate venipuncture and dedicated, trained collectors, supported by a high-quality Level III systematic review. It is good for initial specimen diversion, supported by a Level II trial and a Level V economic model. It is good for sterile technique, supported by a high-quality Level V improvement study in a similar setting. It does not support preparation kits alone. Under the Johns Hopkins model's approach to synthesis, this body of evidence is consistent, with good to high quality across several levels, which supports translating the bundle into practice as a pilot with careful measurement rather than as an untested system-wide change (Dang et al., 2021).

What this page is doingThe synthesis distinguishes the strength of evidence for each component and draws a proportionate conclusion about translation, which prepares for the model selection in Module 5.
10

Gaps the Appraisal Revealed

The appraisal also exposed what the evidence does not answer. No included study tested all three bundle components together, so their combined effect is inferred rather than demonstrated. Most studies were conducted in academic centers with dedicated research or improvement staff, while our department is a community emergency department with high nurse turnover. And few studies reported how long improvements lasted beyond a year. These gaps shape the project design: components will be introduced in sequence so that the contribution of each can be seen, implementation support will be planned for a setting without dedicated improvement staff, and measurement will continue for at least 12 months.

What this page is doingIdentifying evidence gaps and showing how they shape the project design demonstrates that appraisal informs decisions.
11

Conclusion

Appraising by level and quality shows that the proposed bundle rests on uneven evidence: strongest for venipuncture and trained collectors, good for diversion and sterile technique, and absent for kits alone. The appraisal changes the project in one way: preparation kits will not be purchased as a stand-alone intervention. It also confirms that the bundle should be tested as an improvement project with measurement, since the best evidence for some components comes from single sites.

What this page is doingThe conclusion shows how appraisal changes the project, which demonstrates that appraisal is a decision tool, not a formality.
12

References

Dang, D., Dearholt, S. L., Bissett, K., Ascenzi, J., & Whalen, M. (2021). Johns Hopkins evidence-based practice for nurses and healthcare professionals: Model and guidelines (4th ed.). Sigma Theta Tau International.

Doern, G. V., Carroll, K. C., Diekema, D. J., Garey, K. W., Rupp, M. E., Weinstein, M. P., & Sexton, D. J. (2019). Practical guidance for clinical microbiology laboratories: A comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem. Clinical Microbiology Reviews, 33(1), Article e00009-19. https://doi.org/10.1128/CMR.00009-19

Rupp, M. E., Cavalieri, R. J., Marolf, C., & Lyden, E. (2017). Reduction in blood culture contamination through use of initial specimen diversion device. Clinical Infectious Diseases, 65(2), 201-205. https://doi.org/10.1093/cid/cix304

Self, W. H., Speroff, T., Grijalva, C. G., McNaughton, C. D., Ashburn, J., Liu, D., Arbogast, P. G., Russ, S., Storrow, A. B., & Talbot, T. R. (2013). Reducing blood culture contamination in the emergency department: An interrupted time series quality improvement study. Academic Emergency Medicine, 20(1), 89-97. https://doi.org/10.1111/acem.12057

Skoglund, E., Dempsey, C. J., Chen, H., & Garey, K. W. (2019). Estimated clinical and economic impact through use of a novel blood collection device to reduce blood culture contamination in the emergency department: A cost-benefit analysis. Journal of Clinical Microbiology, 57(1), Article e01015-18. https://doi.org/10.1128/JCM.01015-18

Snyder, S. R., Favoretto, A. M., Baetz, R. A., Derzon, J. H., Madison, B. M., Mass, D., Shaw, C. S., Layfield, C. D., Christenson, R. H., & Liebow, E. B. (2012). Effectiveness of practices to reduce blood culture contamination: A Laboratory Medicine Best Practices systematic review and meta-analysis. Clinical Biochemistry, 45(13-14), 999-1011. https://doi.org/10.1016/j.clinbiochem.2012.06.007

What the DNP860 Module 3 instructions ask for

Aspen's DNP860 Module 3 usually asks you to appraise the evidence from your search using a recognized model, rating each source by level and quality. Explain the model's levels and quality grades before using them. For each source, describe the design, sample and main findings, then assign a level and a quality rating and explain both. Note strengths and weaknesses specific to the study rather than generic ones. Synthesize across sources: what does the body of evidence support, and how strongly? Name gaps the appraisal reveals. Show how the appraisal changes your project. Choose five or six key sources rather than all of them, and make sure the ratings match the model's own definitions, since graders will check them against the tool.

Inside the DNP860 Module 3 example

The introduction states that summarizing findings is not appraisal. The framework section explains the Johns Hopkins levels and the quality grades of high, good and low. Source one, the meta-analysis, is rated Level III because it pools observational studies, with high quality for its method. Source two, the diversion trial, is rated Level II with notes on its single academic site. Source three, the sterile collection project, is rated for its interrupted time series design and large sample. Source four, the review, is rated Level V as expert guidance. Source five, the economic model, is rated Level V and checked for its assumptions. The synthesis ranks support by component, the gaps section names untested combinations, and the conclusion explains how the project changes.

Reading the DNP860 Module 3 grading rubric

A DNP860 appraisal is rewarded for applying the model faithfully, with accurate levels, justified quality ratings, synthesis across sources and links to the project. This example rates a meta-analysis of observational studies as Level III rather than Level I, which shows understanding of the model rather than reliance on labels. Dang and colleagues' 2021 Johns Hopkins guide supplies the framework. Snyder's 2012 review, Rupp's 2017 trial in Clinical Infectious Diseases, Self's 2013 study in Infection Control and Hospital Epidemiology, Doern's 2019 review and Skoglund's 2019 model are each rated with reasons. Graders reward a synthesis that ranks components by strength of evidence, and the gaps section shows critical thinking about what remains unknown.

DNP860 Module 3 help: mistakes that cost marks

Appraisal papers often rate every systematic review as Level I. Check what the review pooled. Another common gap is quality ratings with no reasons; tie each to the study's design and conduct. Students also summarize each source and skip synthesis. Compare across sources. Note setting limits, such as academic centers, that affect your own site. Do not treat economic models or expert reviews as trials. Use the model's own wording for levels and grades. Name what the evidence does not answer. Keep to the key sources. End by stating one way the appraisal changes your project, since that is what turns the exercise into decision making for the department you work in.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official Aspen University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.

More DNP860 and DNP sample papers

DNP860 Module 3 questions, answered

What does DNP860 Module 3 usually ask for?

The module often asks you to appraise the studies from your search by level of evidence and quality using a named hierarchy, rather than summarizing their findings. Aspen does not publish module deliverables, so your classroom's instructions govern.

What are the Johns Hopkins levels of evidence?

Level I, experimental studies and systematic reviews of them; Level II, quasi-experimental studies; Level III, nonexperimental and qualitative studies; Level IV, expert committee opinion and guidelines; Level V, literature reviews, quality improvement, program and financial evaluations and expert opinion. Each is rated A, B or C for quality.

Can a lower-level study still be important?

Yes. A well-designed quality improvement study in a setting like yours may be more applicable than a higher-level study elsewhere. Appraisal weighs strength, quality and fit together.

Where can I find a free DNP860 Module 3 sample paper?

The full DNP860 Module 3 paper is above, appraising five sources on blood culture contamination by Johns Hopkins level and quality.

Why is the meta-analysis rated Level III in DNP860 Module 3?

Because it pooled observational studies rather than randomized trials. The Johns Hopkins model places a review at the level of the studies it combines, though its method still rates high quality.